Verifying…
Home / Drug A–Z / Nazol Capsules

Nazol Capsules

NAFDAC Reg. No. A4-4683 · Drug

Registered with NAFDAC. Registration activeAs of 27 October 2026 · synced automatically from official sources.
Product
Nazol Capsules
NAFDAC number
A4-4683
Active ingredient
Danazol
Strength
200 mg
Form
Capsule
Pack size
3 x 10's (in Alu-PVC blisters)
Manufacturer
Not listed
Applicant (holder)
Chez Resources Pharmaceutical Limited
Approved
30 Jan 2025
Status
Active View on NAFDAC ↗
Registration valid to
29 Jan 2030
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Nazol Capsules is on the NAFDAC register with an active registration (A4-4683). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

What Nazol Capsules is used for

From the official U.S. FDA label for danazol, the active ingredient registered with NAFDAC.

Boxed warning: Use of danazol in pregnancy is contraindicated. A sensitive test (e.g., beta subunit test if available) capable of determining early pregnancy is recommended immediately prior to start of therapy. Additionally a non-hormonal method of contraception should be used during therapy. If a patient becomes pregnant while taking danazol, administration of the drug should be discontinued and the patient should be apprised of the potential risk to the fetus. …
What it is used for

Endometriosis. Danazol capsules are indicated for the treatment of endometriosis amenable to hormonal management. Hereditary Angioedema. Danazol capsules are indicated for the prevention of attacks of angioedema of all types (cutaneous, abdominal, laryngeal) in males and females.

Possible side effects

The following events have been reported in association with the use of danazol capsules: Androgen like effects include weight gain, acne and seborrhea. Mild hirsutism, edema, hair loss, voice change, which may take the form of hoarseness, sore throat or of instability or deepening of pitch, may occur and may persist after cessation of therapy. Hypertrophy of the clitoris is rare. Other possible endocrine effects are menstrual disturbances including spotting, alteration of the timing of the cycle and amenorrhea. …

Do not use if

Danazol capsules should not be administered to patients with: Undiagnosed abnormal genital bleeding. Markedly impaired hepatic, renal, or cardiac function. Pregnancy (see WARNINGS ). Breast feeding. Porphyria-Danazol capsules can induce ALA synthetase activity and hence porphyrin metabolism. Androgen-dependent tumor. Active thrombosis or thromboembolic disease and history of such events. Hypersensitivity to danazol.

Warnings

PRECAUTIONS Because danazol capsules may cause some degree of fluid retention, conditions that might be influenced by this factor, such as epilepsy, migraine, or cardiac or renal dysfunction, polycythemia and hypertension require careful observation. Use with caution in patients with diabetes mellitus. Since hepatic dysfunction manifested by modest increases in serum transaminases levels has been reported in patients treated with danazol capsules, periodic liver function tests should be performed (see WARNINGS and ADVERSE REACTIONS ). Administration of danazol has been reported to cause exacerbation of the manifestations of acute intermittent porphyria (see CONTRAINDICATIONS ). …

General information only, not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Nazol Capsules

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Nazol Capsules

What is in Nazol Capsules?

Nazol Capsules contains Danazol (200 mg), as capsule, according to its NAFDAC registration record.

Is Nazol Capsules registered with NAFDAC?

Yes. Nazol Capsules is listed on the NAFDAC register under registration number A4-4683, and its registration is active as of 27 October 2026.

Has Nazol Capsules been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Nazol Capsules in our automatically synced alert list.

How can I check that my pack of Nazol Capsules is genuine?

Run a free authenticity scan with the NAFDAC number A4-4683, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Nazol Capsules used for?

Endometriosis. Danazol capsules are indicated for the treatment of endometriosis amenable to hormonal management. Hereditary Angioedema. Danazol capsules are indicated for the prevention of attacks of angioedema of all types (cutaneous, abdominal, laryngeal) in males and females. (Summarised from the official U.S. FDA label for danazol. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Nazol Capsules? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.